Constucts used in individual detection system and short description of detection systems:

Flow cytometry

Used composite parts: NFκB-MyD-Luc ([http://partsregistry.org/Part:BBa_J52014 BBa_J52014]).

Figure 15: Ota working on the flow cytometer.

Flow cytometry is a sophisticated method, which gives very precise and highly valuable results. The main advantage of this method is that measurements are done on individual cells, so the results are not the average value of the population. In our project we could detect cellular activation based on the phosphorylation cascade activation and anti-phosphoprotein antibodies. In our experiments we used primary antibodies (Ab) from mouse, which specifically detect only phosphorylated form of ERK kinase (pERK). The secondary antibodies used were anti-mouse Abs labelled with a fluorescence marker phycoerithrin (PE), which we can detect on flow cytometer. Cells were transfected with TLR5 or TLR4/MD-2 and with or without dnMyD88, which is under NF-κB promoter. On the second day the cells were stimulated with flagellin or LPS (depends on the selected TLR receptor). According to the literature phosphorylation of ERK can already be detected after 15 min. The amount of pERK kinase increases for additional 20 min and then it starts to decline. After 40 min no pERK is detected.

We used pulsed stimulation of cells. First we stimulated cells with 5 ng/ml of flagellin to activate the expression of dnMyD88. We repeated the stimulation with the second, stronger stimulus (50 ng/ml of flagellin) at different time intervals (2, 4, 6 and 8 hours after the first stimulation. 30 min after the second stimulus cells were fixed in 2% paraformaldehid, permeabilized with ice cold methanol and stained for pERK and secondary Ab labelled with PE.

Expected results: The activation of the signaling pathway also activates the expression of dominant negative protein MyD88, which should block the signaling, so we expect to detect decreased amount of pERK kinase after second stimulation in comparison to cells without of inducible dnMyD88.

Detection of transcriptional activation by luminometry

Used composite parts: NFκB-MyD-luc ([http://partsregistry.org/Part:BBa_J52014 BBa_J52014]), NFκB-MyD-luc-PEST([http://partsregistry.org/Part:BBa_J52024 BBa_J52024]), NFκB-luc-PEST([http://partsregistry.org/Part:BBa_J52023 BBa_J52023]), CMV-luc([http://partsregistry.org/Part:BBa_J52038 BBa_J52038]) and CMV-luc-PEST([http://partsregistry.org/Part:BBa_J52039 BBa_J52039]).

Figure 16: Mithras luminometer.

Luminometry is one of the most sensitive methods to measure the activation of signaling pathways. In many cases it replaced ELISA because it is much more sensitive. The basis of the method is the measurement of light, which is emitted in the enzymatically catalysed reaction. We used two different enzymes (firefly luciferase - fLuc and renilla luciferase - rLuc), which recognize and cleave two different substrates, so we can measure the activity of both enzymes in one sample, which allows the normalization, which corrects for the differences in the cell number, degree of transfection as well as for the cell viability. Each reporter plasmid, where the transcription of luciferase is controled by a defined promoter is introduced into the mammalian cells. Therefore the level of luciferase activity is proportional to the amount of a defined transcription factor, such as NF-κB.

Different variants of the method were used:

1. To be able to measure the activation of dnMyD88 expression after stimulation, we prepared dnMyD88 construct under NF-κB inducible promoter in the fusion with rLuc (construct NF-κB-MyD-luc). We transfected cells with TLR receptor plasmid, biobrick and fLuc under NF-κB promoter plasmid as a positive control. Cells were stimulated and the expression of luciferases was measured in time intervals. We expect that amount of rLuc will increase in time only if cells are stimulated with a ligand.

2. CMV-luc-PEST biobrick was constructed to measure the kinetics of degradation of proteins in fusion with PEST. Cells were transfected with the construct, which is under constitutive promoter. We found out that it takes four hours after the transfection to detect luciferase activity. To calculate half-life of rLuc and rLuc-PEST we transfected cells with those two constructs, incubated to allow proteins to sythesize. New protein synthesis was inhibited by adding cycloheximide and in time intervals the activity of rluc was measured. Because the addition of cycloheximide stops the sythesis of new proteins after time there should be a decrease in rLuc activity due to protein degradation. A construct with PEST should decrease more rapidly as rLuc alone.

ELISA for detection of transcription factors

Figure 17: Schematic representation of the ELISA for detection of the transcriptionally-active NFκB.

Used composite parts: NF-κB–dnMyD88 ([http://partsregistry.org/Part:BBa_J52036 BBa_J52036]) and NFκB–TRAF6–GFP ([http://partsregistry.org/Part:BBa_J52022 BBa_J52022]).

With ELISA detection system we can detect the free NF-κB transcription factor, which is one of the most direct measurements of the pathway activation. Active form of this protein is present after the activation of signaling pathway, when the protein is released from the complex with IκB inhibitor. Free NF-κB migrates into the nucleus where it acts as a transcription activator. We are using high bind 96-well plates coated with [http://en.wikipedia.org/wiki/Streptavidin streptavidin](we prepare them ourselves). The probe for free NF-κB is a biotinylated double stranded oligonucleotide containing NF-κB binding sequence. The NF-κB protein from the whole cell lysate is captured by a probe, whose biotin group binds to the streptavidin coated on the plate. We detect NF-κB bound to its recognition sequence with primary mouse antibodies and secondary peroxidase-conjugated rabbit anti-mouse antibodies. Peroxidase cleaves the substrate which emits light, which is measured on the luminometer.

Confocal microscopy

File:Celica2.gif

Microscope allows localization of signaling molecules within each individual cell, such as translocation of transcription factors, trafficking of proteins fused with reporter fluorescent proteins etc. Therefore this technique should be very usefull particularly for monitoring the expression of dnMyD88 inhibitory domain fused with fluorescent protein and the timecourse of its degradation. Theerfore we designed Parts and several Devices, which included fusion with fluorescent protein:

[http://partsregistry.org/Part:BBa_J52021 BBa_J52021]
[http://partsregistry.org/Part:BBa_J52021 BBa_J52022]
[http://partsregistry.org/Part:BBa_J52021 BBa_J52026]
[http://partsregistry.org/Part:BBa_J52021 BBa_J52027]
[http://partsregistry.org/Part:BBa_J52021 BBa_J52040]
[http://partsregistry.org/Part:BBa_J52021 BBa_J52048].

Problems and Troubleshooting

Construction of Parts using bad oligos

We can only suggest to the other teams in the future to order oligos from a reliable and well established company (not necessarily the onw with the lowest price). When we repeatedly failed to produce PCR products we thought it could have been the beginner's bad luck, but when we determined a huge number of point mutations in the primer region even the mentors decided that we better avoid this company in the future (although they did offer us the replacement of oligos for free). There'll be no next time for this company in our lab.

Theory versus practise

We spent a lot of time to trying to find an answer to the following question: "Why didn't our transformants grow on the LB-Tc plates?". First we accused our our tetracycline, than to the proper concentration, but at the end we found out that one of the previous year's parts was incorrectly registered. Now we know the importance of checking everything twice...

Real-time luminescence

We have attempted to monitor "real time" cell activation using luminescence and invested considerable amount of time and effort into this. We could not detectluminescence in vivo since coelentrazine (substrate of Renilla luciferaze) decays too quickly, while the luciferin could not penetrate the cells. We have also used the caged luciferin as well as its methy esther but in neither case did we suceed in detecting the luciferase in the living cells (several authors of published protocols were unavailable for comments :-( ).

Optimization of activation intervals

Much od lab work (more than initially planned) was devoted to the design of experiments to monitor cell activation. We had to find out the optimal concentration of inducers, the timespan between the first and second activation which gave the best difference, lenght of the experiment in which difference between genetically engineered and wild-type cells would be sufficiently prominent etc. Methods from the literature could not simply be adopted into our experimental procedure.